Identification and Treatment of Major Depressive Disorder

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2016 Fall Forum. If you participated in
the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 31, 2017 to January 31, 2018

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.  To print or save your certificate, you will need to click on the “download” button and either print or save.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This educational activity is supported by educational grants from
Otsuka America Pharmaceuticals and Lundbeck

Major depressive disorder (MDD) is treatable and the earlier treatment starts, the better the outcomes. More than 80% of patients with depression have a medical comorbidity and recent studies show that prolonged depression may raise the risk of stroke and type 2 diabetes. Isolation, personal conflicts, an increase in the use of alcohol or substance abuse and an chance of suicide are also a major concern. These studies show the importance of using approved evidence-based guidelines to choose an appropriate treatment management plan. MDD can be effectively treated and allow the patient to live without debilitating depression as there are several different treatment programs; usually medication and psychotherapy are effective. Newer antidepressant medications have been shown to effectively decrease the symptoms of MDD. Some effective treatments, specifically antidepressants, are currently limited by factors that affect treatment adherence and bring about different side-effects. Recent data showing antidepressant combinations with different mechanisms of action can be a better strategy prior to augmentation with other drug classes. Combination therapies, including multiple pharmacological actions, can affect multiple monoamine targets which can produce greater efficacy.

Upon Completion of this activity, participants will be able to:

  • Assess the safety and efficacy of current and emerging treatment options including the mechanisms of action in novel agents

  • Discuss the importance of screening for major depressive disorder in primary care

  • Identify individualized treatment plans for patients with MDD that include the latest pharmacologic treatment options

  • Analyze combination antidepressant therapy strategies to determine appropriate management plans to avoid unnecessary treatment failures

  • Explore effective communication strategies with patients about depression symptoms, treatments, adherence and barriers to achieving optimal outcomes

Faculty: Jair C. Soares, MD, PhD
Professor and Chairman
Pat R. Rutherford Chair in Psychiatry
Department of Psychiatry and Behavioral Sciences
Executive Director, UT Harris County Psychiatric Center
Director, UT Center of Excellence on Mood Disorders
UTHealth School of Medicine


Dr. Soares receives research funding from Bristol Myers Squibb, Elan, Forrest, Johnson & Johnson and Merck and serves as a consultant to Astellas. In the past, he served on an advisory board for Abbott and Pfizer. His presentation has been peer reviewed.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jacquelyn Smith, RN, BSN, MA, CMCN has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
Will Williams has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

The National Association of Managed Care Physicians designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity and turn in a validation form will receive up to 1 credit in continuing nursing education.

The American Board of Managed Care Nurses has approved this activity for a maximum of 1 contact hour towards CMCN recertification.

This educational activity is supported by educational grants from
Otsuka America Pharmaceuticals and Lundbeck

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue